ABOS vs UROY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ABOS

45.8
AI Score
VS
ABOS Wins

UROY

34.3
AI Score

Investment Advisor Scores

ABOS

46score
Recommendation
HOLD

UROY

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABOS UROY Winner
Net Income -53.45M 40.25M UROY
Operating Income -53.70M 48.32M UROY
ROE -93.3% 12.9% UROY
ROA -46.1% 10.8% UROY
Total Assets 116.01M 373.32M UROY
Cash 59.44M 241.96M UROY
Current Ratio 2.47 5.94 UROY

Relative Price Performance (Last 90 Days)

ABOS 1M: +16.3% · 3M: +23.2% UROY 1M: +6.5% · 3M: +47.1%

Current Technical Phase

ABOS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.8% over 20 days), RSI 53

RSI (14): 53.5 · Price: $2.92

UROY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (17.4% over 20 days), RSI 55

RSI (14): 55.4 · Price: $4.36

Fundamentals Snapshot

Metric ABOS UROY
Market Cap
Forward P/E -2.0 108.9
Trailing P/E 16.7
Revenue (TTM)
Revenue Growth 0.0% 43.4%
Gross Margin -263.8% 0.3%
Operating Margin 0.0% 0.3%
EPS -1.65 0.27
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ABOS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.